Sensus Healthcare Q4 2025 revenue $4.9M, net loss $3.2M; CMS code boost effective Jan 2026

Sensus Healthcare, Inc.

2025-FY EPS reported -$0.47 revenue$27,482,000

Q4 revenue $4.9M, down from $13.1M YoY; net loss $3.2M ($0.19/sh) vs net income $1.5M ($0.09/sh) in Q4 2024.
Shipped 14 SRT systems in Q4 (8 US, 6 international), up from 6 in Q3 excluding largest customer.
Ended 2025 with $22.1M cash and no debt; full-year revenue $27.5M, net loss $7.7M.
CMS published dedicated CPT codes for SRT effective Jan 1, 2026, providing 300% per-fraction increase and reimbursement certainty.
Expects sequential revenue growth in Q1 2026 and full-year profitability; FDA program delivered 11,411 treatments (+8x YoY).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.